182 related articles for article (PubMed ID: 8824283)
21. Isolation and characterization of proteoglycans secreted by normal and malignant human mammary epithelial cells.
Gowda DC; Bhavanandan VP; Davidson EA
J Biol Chem; 1986 Apr; 261(11):4926-34. PubMed ID: 3082872
[TBL] [Abstract][Full Text] [Related]
22. The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans.
Rapraeger A; Jalkanen M; Endo E; Koda J; Bernfield M
J Biol Chem; 1985 Sep; 260(20):11046-52. PubMed ID: 3161889
[TBL] [Abstract][Full Text] [Related]
23. The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin.
Heremans A; De Cock B; Cassiman JJ; Van den Berghe H; David G
J Biol Chem; 1990 May; 265(15):8716-24. PubMed ID: 2140362
[TBL] [Abstract][Full Text] [Related]
24. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens.
Koda JE; Rapraeger A; Bernfield M
J Biol Chem; 1985 Jul; 260(13):8157-62. PubMed ID: 3159726
[TBL] [Abstract][Full Text] [Related]
25. Multiple forms of heparan sulfate proteoglycans in the Engelbreth-Holm-Swarm mouse tumor. The occurrence of high density forms bearing both heparan sulfate and chondroitin sulfate side chains.
Kato M; Koike Y; Ito Y; Suzuki S; Kimata K
J Biol Chem; 1987 May; 262(15):7180-8. PubMed ID: 2953717
[TBL] [Abstract][Full Text] [Related]
26. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
27. Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells.
Lee RT; Yamamoto C; Feng Y; Potter-Perigo S; Briggs WH; Landschulz KT; Turi TG; Thompson JF; Libby P; Wight TN
J Biol Chem; 2001 Apr; 276(17):13847-51. PubMed ID: 11278699
[TBL] [Abstract][Full Text] [Related]
28. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells.
Camejo G; Fager G; Rosengren B; Hurt-Camejo E; Bondjers G
J Biol Chem; 1993 Jul; 268(19):14131-7. PubMed ID: 8314779
[TBL] [Abstract][Full Text] [Related]
29. Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers.
Hedman K; Johansson S; Vartio T; Kjellén L; Vaheri A; Höök M
Cell; 1982 Mar; 28(3):663-71. PubMed ID: 6210440
[TBL] [Abstract][Full Text] [Related]
30. Heparin induces changes in the synthesis of porcine aortic endothelial cell heparan sulfate proteoglycans.
Morrison P; Lowe-Krentz LJ
Exp Cell Res; 1989 Oct; 184(2):304-15. PubMed ID: 2530099
[TBL] [Abstract][Full Text] [Related]
31. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.
Gao G; Plaas A; Thompson VP; Jin S; Zuo F; Sandy JD
J Biol Chem; 2004 Mar; 279(11):10042-51. PubMed ID: 14701864
[TBL] [Abstract][Full Text] [Related]
32. Proteoglycan and glycosaminoglycan synthesis by cultured rat mesangial cells.
Groggel GC; Hovingh P; Linker A
J Cell Physiol; 1991 Jun; 147(3):455-9. PubMed ID: 1906068
[TBL] [Abstract][Full Text] [Related]
33. Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein.
Kaplan M; Aviram M
Atherosclerosis; 2000 Mar; 149(1):5-17. PubMed ID: 10704609
[TBL] [Abstract][Full Text] [Related]
34. Structural properties of the heparan sulfate proteoglycans of brain.
Ripellino JA; Margolis RU
J Neurochem; 1989 Mar; 52(3):807-12. PubMed ID: 2521892
[TBL] [Abstract][Full Text] [Related]
35. Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans.
Boilard E; Bourgoin SG; Bernatchez C; Poubelle PE; Surette ME
FASEB J; 2003 Jun; 17(9):1068-80. PubMed ID: 12773489
[TBL] [Abstract][Full Text] [Related]
36. Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family.
Lomonte B; Tarkowski A; Bagge U; Hanson LA
Biochem Pharmacol; 1994 Apr; 47(9):1509-18. PubMed ID: 8185661
[TBL] [Abstract][Full Text] [Related]
37. Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin.
Hakala JK; Oörni K; Ala-Korpela M; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1276-83. PubMed ID: 10323780
[TBL] [Abstract][Full Text] [Related]
38. The binding of chondroitin 6-sulfate to plasma low density lipoprotein.
Mourão PA; Pillai S; Di Ferrante N
Biochim Biophys Acta; 1981 May; 674(2):178-87. PubMed ID: 6786361
[TBL] [Abstract][Full Text] [Related]
39. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.
Kokenyesi R; Silbert JE
Biochem Biophys Res Commun; 1995 Jun; 211(1):262-7. PubMed ID: 7779094
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of tissue-type plasminogen activator- binding proteoglycans from human umbilical vein endothelial cells.
Böhm T; Geiger M; Binder BR
Arterioscler Thromb Vasc Biol; 1996 May; 16(5):665-72. PubMed ID: 8963724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
